Method for making a primer and nucleic acid exponential amplification methods using said primer

• US 6,174,709 B1
• Filed: 01/31/1994
• Issued: 01/16/2001
• Est. Priority Date: 12/11/1991
• Status: Expired due to Fees

• Current Assignee: BioVeris Corporation (Roche Holding AG)
• Original Assignee: IGEN International, Inc. (Roche Holding AG)
• Inventors: Kenten, John H., Link, John R.
• Primary Examiner(s): Marschel, Ardin H.
• Application Number:
  US08/221,543
• Time in Patent Office: 2,542 Days
• Field of Search: 435/6, 435/91.1, 435/91.2, 435/810, 436/501, 536/22.1, 536/23.1, 536/24.1, 536/24.3, 536/24.33, 536/25.3, 935/77, 935/78, 935/88
• US Class Current: 435/91.2
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 1/689 for bacteria
• CPC Class Codes: C12Q 1/708 for papilloma
• CPC Class Codes: C12Q 2531/107 Probe or oligonucleotide ligation

Abstract

A process for exponentially amplifying a selected nucleic acid sequence present in a sample, comprising the steps of forming a mixture of the sample and a single primer designed to hybridize with the selected nucleic acid sequence; causing the single primer to hybridize to a single strand of the nucleic acid sequence of interest; forming a duplex product of the nucleic acid by a polymerase reaction; separating the duplex product into single strands; and repeating the preceding steps until the rate of production of the amplification product is exponential and the nucleic acid sequence of interest has been amplified.

Claims

1. A process for exponentially amplifying a naturally occurring target nucleic acid sequence in a sample comprising said target sequence, said process comprising the steps of:

(a) forming a mixture of said sample and a single specified primer, such that the molar ratio of primer to target nucleic acid is at least 1000;

1, and said primer (i) consists of approximately 10-40 bases;

(ii) hybridizes to a first primer site at the 3′

terminal of said target nucleic acid sequence; and

(iii) is at least 7.5% homologous to one or more additional nucleic acid sequences 5′

of said first primer site, such that the complement of at least one of said additional nucleic acid sequences serve as additional insertion site(s) for exponential amplification; and

(b) amplifying said target nucleic acid sequence by

(i) subjecting said mixture to conditions which cause the single primer to form a duplex product of said target nucleic acid sequence by a polymerase reaction;

(ii) subjecting said mixture formed in step (i) to conditions which separate the duplex product into single strands; and

(iii) repeating steps (i) and (ii) until the rate of production of duplex product is exponential and said target nucleic acid sequence has been amplified.

2. A process as recited in claim 1 wherein said primer is at least 30% complementary to one or more additional nucleic acid sequences 5′

of said first primer site.

3. A process as recited in claim 1 wherein a nucleic acid sequence used in step (a) is a product of steps (b)(ii) and (b)(iii).

4. A process as recited in claim 1 wherein said steps are carried out sequentially and at a temperature above 20°

C. by contacting said mixture formed in step (b) with an enzyme that forms amplification products under the conditions provided during steps (b)(ii) and (b)(iii).

5. A process as recited in claim 1 wherein step [(b)(iv)] (b)(iii) is repeated by thermal cycling between a lower temperature at which the primer initiates formation of a duplex product and a higher temperature at which the duplex product is denatured.

6. A process as recited in claim 1 wherein the primer is labeled with a detectable label or a binding substance.

7. A process as recited in claim 6 wherein said label is selected from the group consisting of a luminescent moiety, a radioactive isotope, a metal chelate, a redox active species, a nuclear magnetic resonance isotope, a dye, a marker enzyme, and a first substance able to bind a second substance, wherein said second substance is detectable.

8. A process as recited in claim 7 wherein said label is an electrochemiluminescent label.

9. A process as recited in claim 6 wherein said labeled primer is incorporated into an amplification product of said polymerase reaction.

10. A process as recited in claim 6 wherein said labeled primer is incorporated into said target nucleic acid sequence.

11. A process for exponentially amplifying a naturally occurring target nucleic acid sequence in a sample comprising said target sequence, said process comprising the steps of:

(a) forming a mixture of said sample and a single specified primer, such that the molar ratio of primer to target nucleic acid is at least 1000;

1, and said primer (i) consists of approximately 10-40 bases;

(ii) selectively acts as a primer for a first primer site at the 3′

terminal of said target nucleic acid sequence to generate a first primed sequence having a second priming site for said primer; and

(iii) acts as a printer at said second priming site 3′

of said first primer sequence and said primer is at least 7.5% complementary to said second primer site; and

amplifying said target nucleic acid sequence by

(i) subjecting said mixture to conditions which cause the single primer to form a duplex product of said target nucleic acid sequence by a polymerase reaction;

(ii) subjecting said mixture formed in step (i) to conditions which separate the duplex product into single strands; and

(iii) repeating steps (i) and (ii) until the rate of production of duplex product is exponential and said target nucleic acid sequence has been amplified.

12. A process as recited in claim 11 wherein said primer is at least 30% complementary to one or more additional nucleic acid sequences 5′

of said first primer site.

13. A process as recited in claim 11 wherein a nucleic acid sequence used in step (a) is a product of steps (b)(ii) and (b)(iii).

14. A process as recited in claim 11 wherein said steps are carried out sequentially and at a temperature above 20°

C. by contacting said mixture formed in step (b) with an enzyme that forms amplification products under the conditions provided during steps (b)(ii) and (b)(iii).

15. A process as recited in claim 11 wherein step (b)(iii) is repeated by thermal cycling between a lower temperature at which the primer initiates formation of a duplex product and a higher temperature at which the duplex product is denatured.

(iii) repeating steps (i) and (ii) until the rate of production of duplex product is exponential and said target nucleic acid sequence has been amplified.

16. A process as recited in claim 11 wherein the primer is labeled with a detectable label or a binding substance.

17. A process as recited in claim 16 wherein said label is selected from the group consisting of a luminescent moiety, a radioactive isotope, a metal chelate, a redox active species, a nuclear magnetic resonance isotope, a dye, a marker enzyme, and a first substance able to bind a second substance, wherein said second substance is detectable.

18. A process as recited in claim 17 wherein said label is an electrochemiluminescent label.

19. A process as recited in claim 16 wherein said labeled primer is incorporated into an amplification product of said polymerase reaction.

20. A process as recited in claim 16 wherein said labeled primer is incorporated into said target nucleic acid sequence.

21. A method for making a primer for a single primer exponential amplification process comprising the steps of:

(a) selecting a target nucleic acid sequence;

(b) preparing a putative primer of approximately 10-40 base pairs designed to selectively prime or hybridize to a first primer site located at or near the 3′

terminal of said target nucleic acid sequence, wherein the molar ratio of putative primer to target nucleic acid is at least 1000;

1, and said putative primer is at least 7.5 % homologous to one or more additional nucleic acid sequences 5′

of said first priming site, such that the complement of at least one of said additional nucleic acid sequences serve as an additional primer(s) for exponential amplification; and

(c) conducting an amplification process to confirm that said putative primer is operative for single primer exponential amplification of said target nucleic acid sequence.

22. A method as recited in claim 21 wherein said putative primer is at least 30% homologous to one or more additional nucleic acid sequences 5′

of said first primer site.

23. A method as recited in claim 21 wherein said one or more additional sequences are within 5 kb of said first primer site.

24. A method as recited in claim 21 wherein said one or more additional sequences are within 2 kb of said first primer site.

25. A method for modifying a putative primer to improve its ability to act as a primer in a single primer exponential amplification process relative to an amplification process using an unmodified putative primer, comprising the steps of:

(a) modifying a base of said putative primer, such that said putative primer is (i) non-complementary to a corresponding base in a first primer site located at or near the 3′

terminal of a target nucleic acid sequence; and

(ii) complementary to a base of a second priming site on the complement of said target nucleic acid sequence situated 5′

of said first primer site based on the target nucleic acid sequence; and

(b) conducting a polymerase reaction to confirm that said modified putative primer is operative for single primer exponential amplification of said target nucleic acid sequence and said modified putative primer exhibits improved single primer exponential amplification relative to said unmodified putative primer.